{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:27:42Z","timestamp":1787246862682,"version":"build-2736575974"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F31HL176101"],"award-info":[{"award-number":["F31HL176101"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL117952"],"award-info":[{"award-number":["R01HL117952"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Venous malformation (VM) is the most common subtype of vascular malformation. Due to the chronic nature of this disorder, VM patients face significant morbidity and complications throughout their lives. Current therapeutic options can be limited, but recent advances in understanding the cellular and molecular mechanisms that underly VM pathogenesis provide hope for the discovery of more effective targeted therapies. These advances arise from a greater understanding of the cellular effects of VM-causative mutations, which has been aided by the development of more advanced and physiologically relevant model systems. In this review, we begin by providing a brief overview of the clinical characteristics and genetic driver mutations of the most common subtypes of all vascular anomalies (including vascular tumors and vascular malformations), providing context for our more detailed discussion of these aspects of VM. We further summarize the current treatment options available for VM patients and the advancements that have been made in the use of targeted therapies for these patients. We further discuss recent advances in the development of model systems that can be used to study VM pathogenesis. Finally, we focus this review on the mechanisms that are downstream of mutant TIE2, discussing structural features of the receptor, TIE2 signaling pathways, and its roles in vascular physiology and VM pathology.<\/jats:p>","DOI":"10.1007\/s10456-026-10088-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:50:54Z","timestamp":1787244654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathogenesis and molecular mechanisms of mutant TIE2-driven venous malformation"],"prefix":"10.1007","volume":"29","author":[{"given":"Lindsay J.","family":"Bischoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-0419","authenticated-orcid":false,"given":"Elisa","family":"Boscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"10088_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D et al (2015) Vascular anomalies classification: recommendations from the international society for the study of vascular anomalies. Pediatrics 136(1):e203\u2013e214. https:\/\/doi.org\/10.1542\/peds.2014-3673","journal-title":"Pediatrics"},{"issue":"2","key":"10088_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000113","volume":"6","author":"DC Goldenberg","year":"2025","unstructured":"Goldenberg DC, Vikkula M, Penington A et al (2025) Updated classification of vascular anomalies. A living document from the international society for the study of vascular anomalies classification group. J Vasc Anomalies 6(2):e113. https:\/\/doi.org\/10.1097\/JOVA.0000000000000113","journal-title":"J Vasc Anomalies"},{"issue":"9","key":"10088_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.4329\/wjr.v6.i9.677","volume":"6","author":"JL Nosher","year":"2014","unstructured":"Nosher JL, Murillo PG, Liszewski M, Gendel V, Gribbin CE (2014) Vascular anomalies: a pictorial review of nomenclature, diagnosis and treatment. World J Radiol 6(9):677\u2013692. https:\/\/doi.org\/10.4329\/wjr.v6.i9.677","journal-title":"World J Radiol"},{"issue":"11","key":"10088_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1346-8138.1997.tb02522.x","volume":"24","author":"O Enjolras","year":"1997","unstructured":"Enjolras O (1997) Classification and management of the various superficial vascular anomalies: hemangiomas and vascular malformations. J Dermatol 24(11):701\u2013710. https:\/\/doi.org\/10.1111\/j.1346-8138.1997.tb02522.x","journal-title":"J Dermatol"},{"key":"10088_CR5","first-page":"375","volume":"13","author":"O Enjolras","year":"1997","unstructured":"Enjolras O, Mulliken JB (1997) Vascular tumors and vascular malformations (new issues). Adv Dermatol 13:375\u2013423","journal-title":"Adv Dermatol"},{"issue":"4","key":"10088_CR6","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/bjd.12804","volume":"170","author":"A Munden","year":"2014","unstructured":"Munden A, Butschek R, Tom WL et al (2014) Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol 170(4):907\u2013913. https:\/\/doi.org\/10.1111\/bjd.12804","journal-title":"Br J Dermatol"},{"issue":"1","key":"10088_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpeds.2013.03.080","volume":"163","author":"BA Drolet","year":"2013","unstructured":"Drolet BA, Trenor CC, Brand\u00e3o LR et al (2013) Consensus-derived practice standards plan for complicated kaposiform hemangioendothelioma. J Pediatr 163(1):285\u2013291. https:\/\/doi.org\/10.1016\/j.jpeds.2013.03.080","journal-title":"J Pediatr"},{"key":"10088_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37516-7","author":"S Schrenk","year":"2023","unstructured":"Schrenk S, Bischoff LJ, Goines J et al (2023) MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-023-37516-7","journal-title":"Nat Commun"},{"issue":"2","key":"10088_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ajhg.2016.06.010","volume":"99","author":"YH Lim","year":"2016","unstructured":"Lim YH, Bacchiocchi A, Qiu J et al (2016) GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet 99(2):443\u2013450. https:\/\/doi.org\/10.1016\/j.ajhg.2016.06.010","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10088_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ajhg.2016.03.009","volume":"98","author":"UM Ayturk","year":"2016","unstructured":"Ayturk UM, Couto JA, Hann S et al (2016) Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 98(4):789\u2013795. https:\/\/doi.org\/10.1016\/j.ajhg.2016.03.009","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10088_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00000478-199806000-00005","volume":"22","author":"JM Meis-Kindblom","year":"1998","unstructured":"Meis-Kindblom JM, Kindblom LG (1998) Angiosarcoma of soft tissue: a study of 80 Cases. Am J Surg Pathol 22(6):683","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10088_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/his.14458","volume":"80","author":"D Torrence","year":"2022","unstructured":"Torrence D, Antonescu CR (2022) The genetics of vascular tumors: an update. Histopathology 80(1):19\u201332. https:\/\/doi.org\/10.1111\/his.14458","journal-title":"Histopathology"},{"issue":"8","key":"10088_CR13","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1161\/STR.0000000000000134","volume":"48","author":"CP Derdeyn","year":"2017","unstructured":"Derdeyn CP, Zipfel GJ, Albuquerque FC et al (2017) Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 48(8):e200\u2013e224. https:\/\/doi.org\/10.1161\/STR.0000000000000134","journal-title":"Stroke"},{"issue":"4","key":"10088_CR14","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1172\/JCI98589","volume":"128","author":"L Al-Olabi","year":"2018","unstructured":"Al-Olabi L, Polubothu S, Dowsett K et al (2018) Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest 128(4):1496. https:\/\/doi.org\/10.1172\/JCI98589","journal-title":"J Clin Invest"},{"issue":"1","key":"10088_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejmg.2017.10.004","volume":"61","author":"PE Lapinski","year":"2018","unstructured":"Lapinski PE, Doosti A, Salato V, North P, Burrows PE, King PD (2018) Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation. Eur J Med Genet 61(1):11\u201316. https:\/\/doi.org\/10.1016\/j.ejmg.2017.10.004","journal-title":"Eur J Med Genet"},{"issue":"11","key":"10088_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","volume":"136","author":"M Amyere","year":"2017","unstructured":"Amyere M, Revencu N, Helaers R et al (2017) Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling. Circulation 136(11):1037\u20131048. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.026886","journal-title":"Circulation"},{"issue":"3","key":"10088_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000052","volume":"4","author":"Y Sun","year":"2023","unstructured":"Sun Y, Su L, Zhang Y et al (2023) Genotype\u2013phenotype and genotype\u2013outcome analysis of capillary malformation\u2013arteriovenous malformation. J Vasc Anomal 4(3):e052. https:\/\/doi.org\/10.1097\/JOVA.0000000000000052","journal-title":"J Vasc Anomal"},{"issue":"7","key":"10088_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41436-020-0775-8","volume":"22","author":"J McDonald","year":"2020","unstructured":"McDonald J, Bayrak-Toydemir P, DeMille D, Wooderchak-Donahue W, Whitehead K (2020) Cura\u00e7ao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2). Genet Med 22(7):1201\u20131205. https:\/\/doi.org\/10.1038\/s41436-020-0775-8","journal-title":"Genet Med"},{"issue":"3","key":"10088_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ajmg.1320320302","volume":"32","author":"H Plauchu","year":"1989","unstructured":"Plauchu H, De Chadar\u00e9vian JP, Bideau A, Robert JM (1989) Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 32(3):291\u2013297. https:\/\/doi.org\/10.1002\/ajmg.1320320302","journal-title":"Am J Med Genet"},{"issue":"1","key":"10088_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cps.2010.08.007","volume":"38","author":"A Gupta","year":"2011","unstructured":"Gupta A, Kozakewich H (2011) Histopathology of vascular anomalies. Clin Plast Surg 38(1):31\u201344. https:\/\/doi.org\/10.1016\/j.cps.2010.08.007","journal-title":"Clin Plast Surg"},{"issue":"21","key":"10088_CR21","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","volume":"368","author":"MD Shirley","year":"2013","unstructured":"Shirley MD, Tang H, Gallione CJ et al (2013) Sturge\u2013Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368(21):1971\u20131979. https:\/\/doi.org\/10.1056\/NEJMoa1213507","journal-title":"N Engl J Med"},{"issue":"1","key":"10088_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCRESAHA.121.318142","volume":"129","author":"T M\u00e4kinen","year":"2021","unstructured":"M\u00e4kinen T, Boon LM, Vikkula M, Alitalo K (2021) Lymphatic malformations: genetics, mechanisms and therapeutic strategies. Circ Res 129(1):136\u2013154. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318142","journal-title":"Circ Res"},{"issue":"4","key":"10088_CR23","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","volume":"166","author":"VL Luks","year":"2015","unstructured":"Luks VL, Kamitaki N, Vivero MP et al (2015) Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 166(4):1048-1054.e5. https:\/\/doi.org\/10.1016\/j.jpeds.2014.12.069","journal-title":"J Pediatr"},{"issue":"1","key":"10088_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1191-5","volume":"14","author":"M Ozeki","year":"2019","unstructured":"Ozeki M, Aoki Y, Nozawa A et al (2019) Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis. Orphanet J Rare Dis 14(1):215. https:\/\/doi.org\/10.1186\/s13023-019-1191-5","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10088_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/s10038-020-0794-y","volume":"65","author":"A Nozawa","year":"2020","unstructured":"Nozawa A, Ozeki M, Niihori T, Suzui N, Miyazaki T, Aoki Y (2020) A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease. J Hum Genet 65(11):995\u20131001. https:\/\/doi.org\/10.1038\/s10038-020-0794-y","journal-title":"J Hum Genet"},{"key":"10088_CR26","doi-asserted-by":"publisher","DOI":"10.20517\/2574-1209.2025.143","author":"W Zhou","year":"2026","unstructured":"Zhou W, Zeng L, Chen Y, Zhang F (2026) Pulmonary endothelial heterogeneity shapes divergent molecular vulnerabilities under SMAD4 deficiency. Vessel Plus. https:\/\/doi.org\/10.20517\/2574-1209.2025.143","journal-title":"Vessel Plus"},{"issue":"18","key":"10088_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168352","volume":"133","author":"K Banerjee","year":"2023","unstructured":"Banerjee K, Lin Y, Gahn J et al (2023) SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations. J Clin Invest 133(18):e168352. https:\/\/doi.org\/10.1172\/JCI168352","journal-title":"J Clin Invest"},{"issue":"9","key":"10088_CR28","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.7150\/thno.121154","volume":"16","author":"Y Lin","year":"2026","unstructured":"Lin Y, Hashemi Z, Zhang Q et al (2026) Flow-induced Klf4-Akt signaling links EC cycling to mural cell defects in arterial-venous malformations. Theranostics 16(9):4905\u20134922. https:\/\/doi.org\/10.7150\/thno.121154","journal-title":"Theranostics"},{"issue":"21","key":"10088_CR29","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1161\/CIRCULATIONAHA.118.033842","volume":"138","author":"R Ola","year":"2018","unstructured":"Ola R, K\u00fcnzel SH, Zhang F et al (2018) SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2. Circ 138(21):2379\u20132394. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033842","journal-title":"Circ"},{"issue":"4","key":"10088_CR30","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10456-022-09841-w","volume":"25","author":"F Galeffi","year":"2022","unstructured":"Galeffi F, Snellings DA, Wetzel-Strong SE et al (2022) A novel somatic mutation in GNAQ in a capillary malformation provides insight into molecular pathogenesis. Angiogenesis 25(4):493\u2013502. https:\/\/doi.org\/10.1007\/s10456-022-09841-w","journal-title":"Angiogenesis"},{"issue":"5-6","key":"10088_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0945-053X(01)00150-0","volume":"20","author":"M Vikkula","year":"2001","unstructured":"Vikkula M, Boon LM, Mulliken JB (2001) Molecular genetics of vascular malformations. Matrix Biol 20(5\u20136):327\u2013335. https:\/\/doi.org\/10.1016\/S0945-053X(01)00150-0","journal-title":"Matrix Biol"},{"issue":"3","key":"10088_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000068","volume":"4","author":"A Penington","year":"2023","unstructured":"Penington A, Phillips RJ, Sleebs N, Halliday J (2023) Estimate of the prevalence of vascular malformations. J Vasc Anom 4(3):e068. https:\/\/doi.org\/10.1097\/JOVA.0000000000000068","journal-title":"J Vasc Anom"},{"key":"10088_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03995-8","volume":"20","author":"JR Gallagher","year":"2025","unstructured":"Gallagher JR, Carroll S, Martini J, Kelly M, Buethe MG (2025) Currently managed US prevalence of cutaneous venous malformations (cVMs): a nationally representative, retrospective, real-world, subject-blinded, physician-observational probability study. Orphanet J Rare Dis 20:504. https:\/\/doi.org\/10.1186\/s13023-025-03995-8","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10088_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/SAP.0b013e31821453c8","volume":"68","author":"AH Hassanein","year":"2012","unstructured":"Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK (2012) Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg 68(2):198\u2013201. https:\/\/doi.org\/10.1097\/SAP.0b013e31821453c8","journal-title":"Ann Plast Surg"},{"issue":"6","key":"10088_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.21037\/cdt.2016.11.10","volume":"6","author":"S Behravesh","year":"2016","unstructured":"Behravesh S, Yakes W, Gupta N et al (2016) Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther 6(6):557\u2013569. https:\/\/doi.org\/10.21037\/cdt.2016.11.10","journal-title":"Cardiovasc Diagn Ther"},{"issue":"5","key":"10088_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/pde.12162","volume":"30","author":"SA Vogel","year":"2013","unstructured":"Vogel SA, Hess CP, Dowd CF et al (2013) Early versus later presentations of venous malformations: where and why? Pediatr Dermatol 30(5):534\u2013540. https:\/\/doi.org\/10.1111\/pde.12162","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"10088_CR37","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/archdermatol.2009.296","volume":"145","author":"A Dompmartin","year":"2009","unstructured":"Dompmartin A, Ballieux F, Thibon P et al (2009) Elevated D-dimer level is diagnostic for venous malformations. Arch Dermatol 145(11):1239\u20131244. https:\/\/doi.org\/10.1001\/archdermatol.2009.296","journal-title":"Arch Dermatol"},{"issue":"1","key":"10088_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/1358863X18802007","volume":"24","author":"L Hu","year":"2019","unstructured":"Hu L, Chen H, Yang X et al (2019) Risk factors associated with pain in patients with venous malformations of the extremities. Vasc Med 24(1):56\u201362. https:\/\/doi.org\/10.1177\/1358863X18802007","journal-title":"Vasc Med"},{"issue":"7","key":"10088_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1001\/archderm.144.7.873","volume":"144","author":"A Dompmartin","year":"2008","unstructured":"Dompmartin A, Acher A, Thibon P et al (2008) Association of localized intravascular coagulopathy with venous malformations. Arch Dermatol 144(7):873\u2013877. https:\/\/doi.org\/10.1001\/archderm.144.7.873","journal-title":"Arch Dermatol"},{"issue":"7","key":"10088_CR40","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archderm.144.7.861","volume":"144","author":"E Mazoyer","year":"2008","unstructured":"Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L (2008) Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol 144(7):861\u2013867. https:\/\/doi.org\/10.1001\/archderm.144.7.861","journal-title":"Arch Dermatol"},{"issue":"3","key":"10088_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ad.2022.10.035","volume":"114","author":"A Fernandez-Flores","year":"2023","unstructured":"Fernandez-Flores A, Cassarino D, Colmenero I (2023) Vascular malformations: a histopathologic and conceptual appraisal. Actas Dermo-Sifiliogr 114(3):213\u2013228. https:\/\/doi.org\/10.1016\/j.ad.2022.10.035","journal-title":"Actas Dermo-Sifiliogr"},{"issue":"1","key":"10088_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ng.272","volume":"41","author":"N Limaye","year":"2009","unstructured":"Limaye N, Wouters V, Uebelhoer M et al (2009) Somatic mutations in the angiopoietin-receptor TIE2 can cause both solitary and multiple sporadic venous malformations. Nat Genet 41(1):118\u2013124. https:\/\/doi.org\/10.1038\/ng.272","journal-title":"Nat Genet"},{"issue":"17","key":"10088_CR43","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1093\/hmg\/ddt198","volume":"22","author":"M Uebelhoer","year":"2013","unstructured":"Uebelhoer M, N\u00e4tynki M, Kangas J et al (2013) Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB. Hum Mol Genet 22(17):3438\u20133448. https:\/\/doi.org\/10.1093\/hmg\/ddt198","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10088_CR44","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm.1877","volume":"14","author":"M Jinnin","year":"2008","unstructured":"Jinnin M, Medici D, Park L et al (2008) Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14(11):1236\u20131246. https:\/\/doi.org\/10.1038\/nm.1877","journal-title":"Nat Med"},{"issue":"5","key":"10088_CR45","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1161\/STROKEAHA.118.022314","volume":"50","author":"A Zafar","year":"2019","unstructured":"Zafar A, Quadri SA, Farooqui M et al (2019) Familial cerebral cavernous malformations. Stroke 50(5):1294\u20131301. https:\/\/doi.org\/10.1161\/STROKEAHA.118.022314","journal-title":"Stroke"},{"issue":"4","key":"10088_CR46","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1086\/339492","volume":"70","author":"P Brouillard","year":"2002","unstructured":"Brouillard P, Boon LM, Mulliken JB et al (2002) Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (\u201cglomangiomas\u201d). Am J Hum Genet 70(4):866\u2013874. https:\/\/doi.org\/10.1086\/339492","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10088_CR47","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/hmg\/3.9.1583","volume":"3","author":"LM Boon","year":"1994","unstructured":"Boon LM, Mulliken JB, Vikkula M et al (1994) Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet 3(9):1583\u20131587. https:\/\/doi.org\/10.1093\/hmg\/3.9.1583","journal-title":"Hum Mol Genet"},{"key":"10088_CR48","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/s0092-8674(00)81814-0","volume":"87","author":"M Vikkula","year":"1996","unstructured":"Vikkula M, Boon LM, Carraway KL et al (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181\u20131190. https:\/\/doi.org\/10.1016\/s0092-8674(00)81814-0","journal-title":"Cell"},{"issue":"7","key":"10088_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/hmg\/8.7.1279","volume":"8","author":"JT Calvert","year":"1999","unstructured":"Calvert JT, Riney TJ, Kontos CD et al (1999) Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8(7):1279\u20131289. https:\/\/doi.org\/10.1093\/hmg\/8.7.1279","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10088_CR50","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ejhg.2009.193","volume":"18","author":"V Wouters","year":"2010","unstructured":"Wouters V, Limaye N, Uebelhoer M et al (2010) Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 18(4):414\u2013420. https:\/\/doi.org\/10.1038\/ejhg.2009.193","journal-title":"Eur J Hum Genet"},{"issue":"332","key":"10088_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9982","volume":"8","author":"SD Castillo","year":"2016","unstructured":"Castillo SD, Tzouanacou E, Zaw-Thin M et al (2016) Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans. Sci Transl Med 8(332):332ra43. https:\/\/doi.org\/10.1126\/scitranslmed.aad9982","journal-title":"Sci Transl Med"},{"issue":"332","key":"10088_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/SCITRANSLMED.AAF1164","volume":"8","author":"P Castel","year":"2016","unstructured":"Castel P, Carmona FJ, Grego-Bessa J et al (2016) Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med 8(332):332ra42. https:\/\/doi.org\/10.1126\/SCITRANSLMED.AAF1164","journal-title":"Sci Transl Med"},{"issue":"6","key":"10088_CR53","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","volume":"97","author":"N Limaye","year":"2015","unstructured":"Limaye N, Kangas J, Mendola A et al (2015) Somatic activating PIK3CA mutations cause venous malformation. Am J Hum Genet 97(6):914\u2013921. https:\/\/doi.org\/10.1016\/j.ajhg.2015.11.011","journal-title":"Am J Hum Genet"},{"issue":"15","key":"10088_CR54","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/hmg\/ddaf077","volume":"34","author":"N Sikta","year":"2025","unstructured":"Sikta N, Gooley S, Green TE et al (2025) Improving genetic diagnostic yield in familial and sporadic cerebral cavernous malformations: detection of copy number and deep intronic variants. Hum Mol Genet 34(15):1286\u20131293. https:\/\/doi.org\/10.1093\/hmg\/ddaf077","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10088_CR55","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1086\/426952","volume":"76","author":"F Bergametti","year":"2005","unstructured":"Bergametti F, Denier C, Labauge P et al (2005) Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 76(1):42\u201351. https:\/\/doi.org\/10.1086\/426952","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10088_CR56","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/CIRCRESAHA.121.318145","volume":"129","author":"A Queisser","year":"2021","unstructured":"Queisser A, Seront E, Boon LM, Vikkula M (2021) Genetic basis and therapies for vascular anomalies. Circ Res 129(1):155\u2013173. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318145","journal-title":"Circ Res"},{"issue":"4","key":"10088_CR57","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68(4):820\u2013823. https:\/\/doi.org\/10.1073\/pnas.68.4.820","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10088_CR58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jocn.2012.05.041","volume":"20","author":"S Tsutsumi","year":"2013","unstructured":"Tsutsumi S, Ogino I, Miyajima M et al (2013) Genomic causes of multiple cerebral cavernous malformations in a Japanese population. J Clin Neurosci 20(5):667\u2013669. https:\/\/doi.org\/10.1016\/j.jocn.2012.05.041","journal-title":"J Clin Neurosci"},{"issue":"7862","key":"10088_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren AA, Snellings DA, Su SY et al (2021) PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594(7862):271\u2013276. https:\/\/doi.org\/10.1038\/s41586-021-03562-8","journal-title":"Nature"},{"issue":"11","key":"10088_CR60","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre M, Miyagishima D, Bielle F et al (2021) Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N Engl J Med 385(11):996\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa2100440","journal-title":"N Engl J Med"},{"issue":"3","key":"10088_CR61","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s44161-022-00035-7","volume":"1","author":"DA Snellings","year":"2022","unstructured":"Snellings DA, Girard R, Lightle R et al (2022) Developmental venous anomalies are a genetic primer for cerebral cavernous malformations. Nat Cardiovasc Res 1(3):246\u2013252. https:\/\/doi.org\/10.1038\/s44161-022-00035-7","journal-title":"Nat Cardiovasc Res"},{"issue":"9","key":"10088_CR62","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1161\/ATVBAHA.120.314586","volume":"40","author":"K Wang","year":"2020","unstructured":"Wang K, Zhang H, He Y et al (2020) Mural cell-specific deletion of cerebral cavernous malformation 3 in the brain induces cerebral cavernous malformations. Arterioscler Thromb Vasc Biol 40(9):2171\u20132186. https:\/\/doi.org\/10.1161\/ATVBAHA.120.314586","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10088_CR63","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1242\/jcs.059329","volume":"123","author":"MG Lampugnani","year":"2010","unstructured":"Lampugnani MG, Orsenigo F, Rudini N et al (2010) CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 123(7):1073\u20131080. https:\/\/doi.org\/10.1242\/jcs.059329","journal-title":"J Cell Sci"},{"issue":"4","key":"10088_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000348327","volume":"4","author":"J Soblet","year":"2013","unstructured":"Soblet J, Limaye N, Uebelhoer M, Boon LM, Vikkula M (2013) Variable somatic TIE2 mutations in half of sporadic venous malformations. Mol Syndromol 4(4):179\u2013183. https:\/\/doi.org\/10.1159\/000348327","journal-title":"Mol Syndromol"},{"key":"10088_CR65","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.humpath.2024.02.004","volume":"145","author":"K Hirose","year":"2024","unstructured":"Hirose K, Hori Y, Ozeki M et al (2024) Comprehensive phenotypic and genomic characterization of venous malformations. Hum Pathol 145:48\u201355. https:\/\/doi.org\/10.1016\/j.humpath.2024.02.004","journal-title":"Hum Pathol"},{"key":"10088_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14667","author":"R Ghasemi","year":"2024","unstructured":"Ghasemi R, Corliss MM, Bowling KM et al (2024) Comprehensive analysis of TEK variants in patients with vascular malformations. Clin Genet. https:\/\/doi.org\/10.1111\/cge.14667","journal-title":"Clin Genet"},{"issue":"4","key":"10088_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jvsv.2020.11.016","volume":"9","author":"Z Du","year":"2021","unstructured":"Du Z, Liu JL, You YH et al (2021) Genetic landscape of common venous malformations in the head and neck. J Vasc Surg Venous Lymphat Disord 9(4):1007-1016.e7. https:\/\/doi.org\/10.1016\/j.jvsv.2020.11.016","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"2","key":"10088_CR68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ajhg.2012.12.017","volume":"92","author":"M Amyere","year":"2013","unstructured":"Amyere M, Aerts V, Brouillard P et al (2013) Somatic uniparental isodisomy explains multifocality of glomuvenous malformations. Am J Hum Genet 92(2):188\u2013196. https:\/\/doi.org\/10.1016\/j.ajhg.2012.12.017","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10088_CR69","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006119","volume":"7","author":"CL Sudduth","year":"2021","unstructured":"Sudduth CL, Konczyk DJ, Smits PJ et al (2021) Bockenheimer disease is associated with a TEK variant. Mol Case Stud 7(6):a006119. https:\/\/doi.org\/10.1101\/mcs.a006119","journal-title":"Mol Case Stud"},{"issue":"5","key":"10088_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0190-9622(03)02468-X","volume":"50","author":"WK Nahm","year":"2004","unstructured":"Nahm WK, Moise S, Eichenfield LF et al (2004) Venous malformations in blue rubber bleb nevus syndrome: variable onset of presentation. J Am Acad Dermatol 50(5):101\u2013106. https:\/\/doi.org\/10.1016\/S0190-9622(03)02468-X","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10088_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jid.2016.07.034","volume":"137","author":"J Soblet","year":"2017","unstructured":"Soblet J, Kangas J, N\u00e4tynki M et al (2017) Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol 137(1):207\u2013216. https:\/\/doi.org\/10.1016\/j.jid.2016.07.034","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10088_CR72","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/nrd4204","volume":"13","author":"DA Fruman","year":"2014","unstructured":"Fruman DA, Rommel C (2014) PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13(2):140\u2013156. https:\/\/doi.org\/10.1038\/nrd4204","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10088_CR73","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/hmg\/ddu505","volume":"24","author":"AJ Osborn","year":"2015","unstructured":"Osborn AJ, Dickie P, Neilson DE et al (2015) Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations. Hum Mol Genet 24(4):926\u2013938. https:\/\/doi.org\/10.1093\/hmg\/ddu505","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10088_CR74","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41431-023-01414-9","volume":"31","author":"G Reynolds","year":"2023","unstructured":"Reynolds G, Cardaropoli S, Carli D et al (2023) Epidemiology of the disorders of the Pik3ca-related overgrowth spectrum (Pros). Eur J Hum Genet 31(11):1333\u20131336. https:\/\/doi.org\/10.1038\/s41431-023-01414-9","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10088_CR75","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1053\/j.ro.2019.06.005","volume":"54","author":"F Bertino","year":"2019","unstructured":"Bertino F, Chaudry G (2019) Overgrowth syndromes associated with vascular anomalies. Semin Roentgenol 54(4):349\u2013358. https:\/\/doi.org\/10.1053\/j.ro.2019.06.005","journal-title":"Semin Roentgenol"},{"key":"10088_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02860-w","volume":"18","author":"B Zhang","year":"2023","unstructured":"Zhang B, He R, Xu Z et al (2023) Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations. Orphanet J Rare Dis 18:261. https:\/\/doi.org\/10.1186\/s13023-023-02860-w","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10088_CR77","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/gcc.22739","volume":"58","author":"RW Ten Broek","year":"2019","unstructured":"Ten Broek RW, Eijkelenboom A, van der Vleuten CJM et al (2019) Comprehensive molecular and clinicopathological analysis of vascular malformations: a study of 319 cases. Genes Chromosomes Cancer 58(8):541\u2013550. https:\/\/doi.org\/10.1002\/gcc.22739","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10088_CR78","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10456-018-9624-7","volume":"21","author":"J Goines","year":"2018","unstructured":"Goines J, Li X, Cai Y et al (2018) A xenograft model for venous malformation. Angiogenesis 21(4):725\u2013735. https:\/\/doi.org\/10.1007\/s10456-018-9624-7","journal-title":"Angiogenesis"},{"key":"10088_CR79","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.125.323387","author":"S Schrenk","year":"2025","unstructured":"Schrenk S, Sherpa C, Bischoff LJ, Cai Y, Boscolo E (2025) Semaphorin 3A and 3F promote lumen expansion in TIE2-mutated venous malformation. Arterioscler Thromb Vasc Biol. https:\/\/doi.org\/10.1161\/ATVBAHA.125.323387","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10088_CR80","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/hmg\/ddn430","volume":"18","author":"AL Akers","year":"2009","unstructured":"Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA (2009) Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 18(5):919\u2013930. https:\/\/doi.org\/10.1093\/hmg\/ddn430","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10088_CR81","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","volume":"123","author":"MR Detter","year":"2018","unstructured":"Detter MR, Snellings DA, Marchuk DA (2018) Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ Res 123(10):1143\u20131151. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313970","journal-title":"Circ Res"},{"issue":"9","key":"10088_CR82","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1007\/s00247-017-3906-x","volume":"47","author":"CM Johnson","year":"2017","unstructured":"Johnson CM, Navarro OM (2017) Clinical and sonographic features of pediatric soft-tissue vascular anomalies part 2: vascular malformations. Pediatr Radiol 47(9):1196\u20131208. https:\/\/doi.org\/10.1007\/s00247-017-3906-x","journal-title":"Pediatr Radiol"},{"issue":"1","key":"10088_CR83","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.crad.2015.09.006","volume":"71","author":"LJ Higgins","year":"2014","unstructured":"Higgins LJ, Koshy J, Mitchell SE et al (2014) Time-resolved contrast-enhanced MRA (TWIST) with gadofosveset trisodium in the classification of soft-tissue vascular anomalies in the head and neck in children following updated 2014 ISSVA classification: first report on systematic evaluation of MRI and TWIST in a cohort of 47 children. Clin Radiol 71(1):32\u201339. https:\/\/doi.org\/10.1016\/j.crad.2015.09.006","journal-title":"Clin Radiol"},{"issue":"2","key":"10088_CR84","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1055\/s-0041-1729743","volume":"38","author":"M Acord","year":"2021","unstructured":"Acord M, Srinivasan A (2021) Management of venous malformations. Semin Interv Radiol 38(2):215\u2013225. https:\/\/doi.org\/10.1055\/s-0041-1729743","journal-title":"Semin Interv Radiol"},{"issue":"1","key":"10088_CR85","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jvsv.2022.08.004","volume":"11","author":"J Cao","year":"2023","unstructured":"Cao J, Liu J, Zhang X, Wang Z (2023) A systematic review and network meta-analysis of the effectiveness of sclerotherapy for venous malformation. J Vasc Surg Venous Lymphat Disord 11(1):210-218.e3. https:\/\/doi.org\/10.1016\/j.jvsv.2022.08.004","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"3","key":"10088_CR86","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jvs.2007.11.026","volume":"47","author":"T Yamaki","year":"2008","unstructured":"Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T (2008) Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg 47(3):578\u2013584. https:\/\/doi.org\/10.1016\/j.jvs.2007.11.026","journal-title":"J Vasc Surg"},{"issue":"4","key":"10088_CR87","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000072","volume":"4","author":"R Rodriguez Colon","year":"2023","unstructured":"Rodriguez Colon R, Cripps C, Blei F, Sharma S (2023) Surgical treatment of vascular anomalies in the extremities: a single surgeon experience. J Vasc Anom 4(4):e072. https:\/\/doi.org\/10.1097\/JOVA.0000000000000072","journal-title":"J Vasc Anom"},{"issue":"4","key":"10088_CR88","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jvsv.2023.02.004","volume":"11","author":"P Gasparella","year":"2023","unstructured":"Gasparella P, Flucher C, Beqo BP et al (2023) Outcome after surgical treatment of venous malformations of the hand in childhood. J Vasc Surg Venous Lymphat Disord 11(4):793\u2013800. https:\/\/doi.org\/10.1016\/j.jvsv.2023.02.004","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"2","key":"10088_CR89","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC, Hammill AM et al (2016) Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137(2):e20153257. https:\/\/doi.org\/10.1542\/peds.2015-3257","journal-title":"Pediatrics"},{"issue":"2","key":"10088_CR90","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S et al (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell 22(2):159\u2013168. https:\/\/doi.org\/10.1016\/j.molcel.2006.03.029","journal-title":"Mol Cell"},{"issue":"22","key":"10088_CR91","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1093\/HMG\/DDV349","volume":"24","author":"M N\u00e4tynki","year":"2015","unstructured":"N\u00e4tynki M, Kangas J, Miinalainen I et al (2015) Common and specific effects of TIE2 mutations causing venous malformations. Hum Mol Genet 24(22):6374. https:\/\/doi.org\/10.1093\/HMG\/DDV349","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10088_CR92","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1172\/JCI76004","volume":"125","author":"E Boscolo","year":"2015","unstructured":"Boscolo E, Limaye N, Huang L et al (2015) Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects. J Clin Invest 125(9):3491. https:\/\/doi.org\/10.1172\/JCI76004","journal-title":"J Clin Invest"},{"issue":"1","key":"10088_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-020-00606-w","volume":"18","author":"Y Si","year":"2020","unstructured":"Si Y, Huang J, Li X et al (2020) AKT\/FOXO1 axis links cross-talking of endothelial cell and pericyte in TIE2-mutated venous malformations. Cell Commun Signal 18(1):139. https:\/\/doi.org\/10.1186\/s12964-020-00606-w","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10088_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48854-2","volume":"9","author":"Y Cai","year":"2019","unstructured":"Cai Y, Schrenk S, Goines J, Davis GE, Boscolo E (2019) Constitutive active mutant TIE2 induces enlarged vascular lumen formation with loss of apico-basal polarity and pericyte recruitment. Sci Rep 9(1):12352. https:\/\/doi.org\/10.1038\/s41598-019-48854-2","journal-title":"Sci Rep"},{"issue":"3","key":"10088_CR95","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/ATVBAHA.118.312315","volume":"39","author":"X Li","year":"2019","unstructured":"Li X, Cai Y, Goines J et al (2019) Ponatinib combined with rapamycin causes regression of murine venous malformation. Arterioscler Thromb Vasc Biol 39(3):496. https:\/\/doi.org\/10.1161\/ATVBAHA.118.312315","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10088_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0934-z","volume":"13","author":"J Hammer","year":"2018","unstructured":"Hammer J, Seront E, Duez S et al (2018) Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis 13(1):191. https:\/\/doi.org\/10.1186\/s13023-018-0934-z","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"10088_CR97","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1001\/jamadermatol.2021.3459","volume":"157","author":"A Maruani","year":"2021","unstructured":"Maruani A, Tavernier E, Boccara O et al (2021) Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical PERFORMUS trial. JAMA Dermatol 157(11):1289\u20131298. https:\/\/doi.org\/10.1001\/jamadermatol.2021.3459","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10088_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvsv.2025.102284","volume":"13","author":"G Wang","year":"2025","unstructured":"Wang G, Lu W, Zhu Y, Wang C, Yang X (2025) Effectiveness and safety of sirolimus in the treatment of venous malformations: a meta-analysis of prospective studies. J Vasc Surg Venous Lymphat Disord 13(6):102284. https:\/\/doi.org\/10.1016\/j.jvsv.2025.102284","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"20","key":"10088_CR99","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","volume":"380","author":"F Andr\u00e9","year":"2019","unstructured":"Andr\u00e9 F, Ciruelos E, Rubovszky G et al (2019) Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N Engl J Med 380(20):1929\u20131940. https:\/\/doi.org\/10.1056\/NEJMoa1813904","journal-title":"N Engl J Med"},{"issue":"1","key":"10088_CR100","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.1038\/s41598-023-37468-4","volume":"13","author":"M Sterba","year":"2023","unstructured":"Sterba M, Pokorna P, Faberova R et al (2023) Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity. Sci Rep 13(1):10499. https:\/\/doi.org\/10.1038\/s41598-023-37468-4","journal-title":"Sci Rep"},{"issue":"10","key":"10088_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29897","volume":"69","author":"A Remy","year":"2022","unstructured":"Remy A, Tran TH, Dubois J et al (2022) Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: preliminary pharmacokinetics and pharmacodynamic data. Pediatr Blood Cancer 69(10):e29897. https:\/\/doi.org\/10.1002\/pbc.29897","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10088_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/app10030938","volume":"10","author":"DJ Medina-Leyte","year":"2020","unstructured":"Medina-Leyte DJ, Dom\u00ednguez-P\u00e9rez M, Mercado I, Villarreal-Molina MT, Jacobo-Albavera L (2020) Use of human umbilical vein endothelial cells (HUVEC) as a model to study cardiovascular disease: a review. Appl Sci 10(3):3. https:\/\/doi.org\/10.3390\/app10030938","journal-title":"Appl Sci"},{"issue":"7","key":"10088_CR103","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade8939","volume":"9","author":"WY Aw","year":"2023","unstructured":"Aw WY, Cho C, Wang H et al (2023) Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1\/2 in lesion formation. Sci Adv 9(7):eade8939. https:\/\/doi.org\/10.1126\/sciadv.ade8939","journal-title":"Sci Adv"},{"issue":"3","key":"10088_CR104","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10456-024-09925-9","volume":"27","author":"B Lazovic","year":"2024","unstructured":"Lazovic B, Nguyen HT, Ansarizadeh M et al (2024) Human iPSC and CRISPR targeted gene knock-in strategy for studying the somatic TIE2L914F mutation in endothelial cells. Angiogenesis 27(3):523\u2013542. https:\/\/doi.org\/10.1007\/s10456-024-09925-9","journal-title":"Angiogenesis"},{"issue":"2","key":"10088_CR105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCRESAHA.117.306290","volume":"117","author":"P Abrahimi","year":"2015","unstructured":"Abrahimi P, Chang WG, Kluger MS et al (2015) Efficient gene disruption in cultured primary human endothelial cells by CRISPR\/Cas9. Circ Res 117(2):121\u2013128. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.306290","journal-title":"Circ Res"},{"issue":"2","key":"10088_CR106","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi Y, Inoue H, Wu JC, Yamanaka S (2017) Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov 16(2):115\u2013130. https:\/\/doi.org\/10.1038\/nrd.2016.245","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"10088_CR107","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ncb3205","volume":"17","author":"C Patsch","year":"2015","unstructured":"Patsch C, Challet-Meylan L, Thoma EC et al (2015) Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol 17(8):994\u20131003. https:\/\/doi.org\/10.1038\/ncb3205","journal-title":"Nat Cell Biol"},{"issue":"30","key":"10088_CR108","doi-asserted-by":"publisher","first-page":"eaba7606","DOI":"10.1126\/sciadv.aba7606","volume":"6","author":"K Wang","year":"2020","unstructured":"Wang K, Lin RZ, Hong X et al (2020) Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. Sci Adv 6(30):eaba7606. https:\/\/doi.org\/10.1126\/sciadv.aba7606","journal-title":"Sci Adv"},{"issue":"4","key":"10088_CR109","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10456-024-09937-5","volume":"27","author":"AC Luo","year":"2024","unstructured":"Luo AC, Wang J, Wang K et al (2024) A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation. Angiogenesis 27(4):779\u2013795. https:\/\/doi.org\/10.1007\/s10456-024-09937-5","journal-title":"Angiogenesis"},{"key":"10088_CR110","doi-asserted-by":"publisher","DOI":"10.3791\/61501","author":"S Schrenk","year":"2020","unstructured":"Schrenk S, Goines J, Boscolo E (2020) A patient-derived xenograft model for venous malformation. J Vis Exp JoVE. https:\/\/doi.org\/10.3791\/61501","journal-title":"J Vis Exp JoVE"},{"issue":"4","key":"10088_CR111","doi-asserted-by":"publisher","first-page":"385","DOI":"10.7150\/ijms.23054","volume":"15","author":"Z Du","year":"2018","unstructured":"Du Z, Ma HL, Zhang ZY, Zheng JW, Wang YA (2018) Transgenic expression of a venous malformation related mutation, TIE2-R849W, significantly induces multiple malformations of zebrafish. Int J Med Sci 15(4):385\u2013394. https:\/\/doi.org\/10.7150\/ijms.23054","journal-title":"Int J Med Sci"},{"issue":"1","key":"10088_CR112","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/hmg\/ddab196","volume":"31","author":"LM Bell","year":"2022","unstructured":"Bell LM, Holm A, Matysiak U et al (2022) Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos. Hum Mol Genet 31(1):10\u201317. https:\/\/doi.org\/10.1093\/hmg\/ddab196","journal-title":"Hum Mol Genet"},{"key":"10088_CR113","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.110896.1","author":"H Brunsdon","year":"2026","unstructured":"Brunsdon H, Wang N, Raredon MSB, Madsen RR, Semple RK, Patton EE (2026) PIK3CA-related overgrowth spectrum (PROS) zebrafish models reveal pan-lineage developmental dysregulation. eLife. https:\/\/doi.org\/10.7554\/eLife.110896.1","journal-title":"eLife"},{"issue":"2","key":"10088_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-017-0064-x","volume":"9","author":"L di Blasio","year":"2018","unstructured":"di Blasio L, Puliafito A, Gagliardi PA et al (2018) PI3K\/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations. Cell Death Dis 9(2):45. https:\/\/doi.org\/10.1038\/s41419-017-0064-x","journal-title":"Cell Death Dis"},{"issue":"7","key":"10088_CR115","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202115619","volume":"14","author":"P Kobialka","year":"2022","unstructured":"Kobialka P, Sabata H, Vilalta O et al (2022) The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib. EMBO Mol Med 14(7):e15619. https:\/\/doi.org\/10.15252\/emmm.202115619","journal-title":"EMBO Mol Med"},{"issue":"4","key":"10088_CR116","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220741","volume":"220","author":"M Petkova","year":"2023","unstructured":"Petkova M, Kraft M, Stritt S et al (2023) Immune-interacting lymphatic endothelial subtype at capillary terminals drives lymphatic malformation. J Exp Med 220(4):e20220741. https:\/\/doi.org\/10.1084\/jem.20220741","journal-title":"J Exp Med"},{"issue":"7","key":"10088_CR117","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s44161-025-00655-9","volume":"4","author":"M Kraft","year":"2025","unstructured":"Kraft M, Schoofs H, Petkova M et al (2025) Angiopoietin\u2013TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Nat Cardiovasc Res 4(7):801\u2013820. https:\/\/doi.org\/10.1038\/s44161-025-00655-9","journal-title":"Nat Cardiovasc Res"},{"key":"10088_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.70087","author":"LJ Bischoff","year":"2025","unstructured":"Bischoff LJ, Schrenk S, Soroko K et al (2025) Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling. Dev Dyn. https:\/\/doi.org\/10.1002\/dvdy.70087","journal-title":"Dev Dyn"},{"issue":"9","key":"10088_CR119","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202600444R","volume":"40","author":"LJ Bischoff","year":"2026","unstructured":"Bischoff LJ, Sherpa C, Schrenk S, Boscolo E (2026) Constitutive, mosaic expression of TIE2 p.L914F during mouse development causes venous malformation. FASEB J 40(9):e71862. https:\/\/doi.org\/10.1096\/fj.202600444R","journal-title":"FASEB J"},{"issue":"3","key":"10088_CR120","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1242\/dev.119.3.957","volume":"119","author":"H Schn\u00fcrch","year":"1993","unstructured":"Schn\u00fcrch H, Risau W (1993) Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119(3):957\u2013968. https:\/\/doi.org\/10.1242\/dev.119.3.957","journal-title":"Development"},{"issue":"2","key":"10088_CR121","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1006\/dbio.2000.0106","volume":"230","author":"YY Kisanuki","year":"2001","unstructured":"Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M (2001) Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230(2):230\u2013242. https:\/\/doi.org\/10.1006\/dbio.2000.0106","journal-title":"Dev Biol"},{"issue":"22","key":"10088_CR122","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1073\/pnas.2133552100","volume":"100","author":"MC Puri","year":"2003","unstructured":"Puri MC, Bernstein A (2003) Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci U S A 100(22):12753\u201312758. https:\/\/doi.org\/10.1073\/pnas.2133552100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10088_CR123","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/dvg.20654","volume":"48","author":"Y Tang","year":"2010","unstructured":"Tang Y, Harrington A, Yang X, Friesel RE, Liaw L (2010) The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genes N Y N 2000 48(9):563\u2013567. https:\/\/doi.org\/10.1002\/dvg.20654","journal-title":"Genes N Y N 2000"},{"issue":"2","key":"10088_CR124","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2004.07.004","volume":"118","author":"F Arai","year":"2004","unstructured":"Arai F, Hirao A, Ohmura M et al (2004) Tie2\/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118(2):149\u2013161. https:\/\/doi.org\/10.1016\/j.cell.2004.07.004","journal-title":"Cell"},{"issue":"12","key":"10088_CR125","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1182\/blood-2006-10-053504","volume":"109","author":"MA Venneri","year":"2007","unstructured":"Venneri MA, De Palma M, Ponzoni M et al (2007) Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109(12):5276\u20135285. https:\/\/doi.org\/10.1182\/blood-2006-10-053504","journal-title":"Blood"},{"issue":"6","key":"10088_CR126","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nsmb1101","volume":"13","author":"WA Barton","year":"2006","unstructured":"Barton WA, Tzvetkova-Robev D, Miranda EP et al (2006) Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2\u2013Tie2 complex. Nat Struct Mol Biol 13(6):524\u2013532. https:\/\/doi.org\/10.1038\/nsmb1101","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"10088_CR127","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1074\/jbc.M208550200","volume":"278","author":"U Fiedler","year":"2003","unstructured":"Fiedler U, Krissl T, Koidl S et al (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats *. J Biol Chem 278(3):1721\u20131727. https:\/\/doi.org\/10.1074\/jbc.M208550200","journal-title":"J Biol Chem"},{"issue":"1","key":"10088_CR128","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1038\/s41467-021-26620-1","volume":"12","author":"G Jo","year":"2021","unstructured":"Jo G, Bae J, Hong HJ et al (2021) Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic antibody. Nat Commun 12(1):6287. https:\/\/doi.org\/10.1038\/s41467-021-26620-1","journal-title":"Nat Commun"},{"issue":"11","key":"10088_CR129","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0969-2126(00)00516-5","volume":"8","author":"LM Shewchuk","year":"2000","unstructured":"Shewchuk LM, Hassell AM, Ellis B et al (2000) Structure of the Tie2 RTK Domain: Self-Inhibition by the Nucleotide Binding Loop, Activation Loop, and C-Terminal Tail. Structure 8(11):1105\u20131113. https:\/\/doi.org\/10.1016\/S0969-2126(00)00516-5","journal-title":"Structure"},{"issue":"6801","key":"10088_CR130","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407(6801):242\u2013248. https:\/\/doi.org\/10.1038\/35025215","journal-title":"Nature"},{"issue":"8","key":"10088_CR131","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/MCB.01472-08","volume":"29","author":"HT Yuan","year":"2009","unstructured":"Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29(8):2011\u20132022. https:\/\/doi.org\/10.1128\/MCB.01472-08","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10088_CR132","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nsb880","volume":"10","author":"S Davis","year":"2003","unstructured":"Davis S, Papadopoulos N, Aldrich TH et al (2003) Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10(1):38\u201344. https:\/\/doi.org\/10.1038\/nsb880","journal-title":"Nat Struct Biol"},{"issue":"15","key":"10088_CR133","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.0307574101","volume":"101","author":"CH Cho","year":"2004","unstructured":"Cho CH, Kammerer RA, Lee HJ et al (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101(15):5547\u20135552. https:\/\/doi.org\/10.1073\/pnas.0307574101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10088_CR134","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1073\/pnas.1216890110","volume":"110","author":"X Yu","year":"2013","unstructured":"Yu X, Seegar TCM, Dalton AC et al (2013) Structural basis for angiopoietin-1\u2013mediated signaling initiation. Proc Natl Acad Sci U S A 110(18):7205\u20137210. https:\/\/doi.org\/10.1073\/pnas.1216890110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10088_CR135","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.molcel.2010.02.007","volume":"37","author":"TCM Seegar","year":"2010","unstructured":"Seegar TCM, Eller B, Tzvetkova-Robev D et al (2010) Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 37(5):643\u2013655. https:\/\/doi.org\/10.1016\/j.molcel.2010.02.007","journal-title":"Mol Cell"},{"issue":"3","key":"10088_CR136","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/s0008-6363(00)00231-5","volume":"49","author":"K Teichert-Kuliszewska","year":"2001","unstructured":"Teichert-Kuliszewska K, Maisonpierre PC, Jones N et al (2001) Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc Res 49(3):659\u2013670. https:\/\/doi.org\/10.1016\/s0008-6363(00)00231-5","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10088_CR137","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis S, Aldrich TH, Jones PF et al (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87(7):1161\u20131169. https:\/\/doi.org\/10.1016\/S0092-8674(00)81812-7","journal-title":"Cell"},{"issue":"5","key":"10088_CR138","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1073\/pnas.96.5.1904","volume":"96","author":"DM Valenzuela","year":"1999","unstructured":"Valenzuela DM, Griffiths JA, Rojas J et al (1999) Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci U S A 96(5):1904\u20131909. https:\/\/doi.org\/10.1073\/pnas.96.5.1904","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10088_CR139","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1128\/MCB.22.6.1704-1713.2002","volume":"22","author":"CD Kontos","year":"2002","unstructured":"Kontos CD, Cha EH, York JD, Peters KG (2002) The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 22(6):1704\u20131713. https:\/\/doi.org\/10.1128\/MCB.22.6.1704-1713.2002","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10088_CR140","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1096\/fj.07-8487com","volume":"21","author":"HT Yuan","year":"2007","unstructured":"Yuan HT, Venkatesha S, Chan B et al (2007) Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J 21(12):3171\u20133183. https:\/\/doi.org\/10.1096\/fj.07-8487com","journal-title":"FASEB J"},{"issue":"9","key":"10088_CR141","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1172\/JCI84923","volume":"126","author":"EA Korhonen","year":"2016","unstructured":"Korhonen EA, Lampinen A, Giri H et al (2016) Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest 126(9):3495\u20133510. https:\/\/doi.org\/10.1172\/JCI84923","journal-title":"J Clin Invest"},{"issue":"11","key":"10088_CR142","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.celrep.2015.08.024","volume":"12","author":"S Savant","year":"2015","unstructured":"Savant S, La Porta S, Budnik A et al (2015) The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells. Cell Rep 12(11):1761\u20131773. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.024","journal-title":"Cell Rep"},{"issue":"6","key":"10088_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061705","volume":"12","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ishibashi M, Kitatani K et al (2020) Potential of Tyrosine Kinase Receptor TIE-1 as novel therapeutic target in high-PI3K-expressing ovarian cancer. Cancers 12(6):1705. https:\/\/doi.org\/10.3390\/cancers12061705","journal-title":"Cancers"},{"issue":"13","key":"10088_CR144","doi-asserted-by":"publisher","DOI":"10.1242\/dev.204469","volume":"152","author":"HS Baldwin","year":"2025","unstructured":"Baldwin HS, Davis MJ, Harmelink C, Qu X (2025) TIE1-dependent lymphatic vascular remodeling is mediated by its second tyrosine kinase domain. Dev Camb Engl 152(13):dev204469. https:\/\/doi.org\/10.1242\/dev.204469","journal-title":"Dev Camb Engl"},{"issue":"14","key":"10088_CR145","doi-asserted-by":"publisher","DOI":"10.1172\/JCI173586","volume":"134","author":"P Brouillard","year":"2024","unstructured":"Brouillard P, Murtom\u00e4ki A, Lepp\u00e4nen VM et al (2024) Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema. J Clin Invest. 134(14):e173586. https:\/\/doi.org\/10.1172\/JCI173586","journal-title":"J Clin Invest."},{"issue":"2","key":"10088_CR146","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-025-10028-2","volume":"29","author":"A Anisimov","year":"2026","unstructured":"Anisimov A, Lackman MH, Augustin HG, Mervaala E, Alitalo K, Karaman S (2026) Deletion of the angiopoietin receptor Tie2 enhances proliferation and sprouting of cardiac endothelial cells. Angiogenesis 29(2):13. https:\/\/doi.org\/10.1007\/s10456-025-10028-2","journal-title":"Angiogenesis"},{"issue":"43","key":"10088_CR147","doi-asserted-by":"publisher","first-page":"5948","DOI":"10.1038\/sj.onc.1202992","volume":"18","author":"G Fachinger","year":"1999","unstructured":"Fachinger G, Deutsch U, Risau W (1999) Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the Angiopoietin receptor Tie-2. Oncogene 18(43):5948\u20135953. https:\/\/doi.org\/10.1038\/sj.onc.1202992","journal-title":"Oncogene"},{"issue":"1","key":"10088_CR148","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00441-023-03844-9","volume":"395","author":"P Baluk","year":"2024","unstructured":"Baluk P, Shirakura K, Vestweber D, McDonald DM (2024) Heterogeneity of endothelial VE-PTP downstream polarization, Tie2 activation, junctional claudin-5, and permeability in the aorta and vena cava. Cell Tissue Res 395(1):81\u2013103. https:\/\/doi.org\/10.1007\/s00441-023-03844-9","journal-title":"Cell Tissue Res"},{"issue":"10","key":"10088_CR149","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1172\/JCI74527","volume":"124","author":"J Shen","year":"2014","unstructured":"Shen J, Frye M, Lee BL et al (2014) Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest 124(10):4564\u20134576. https:\/\/doi.org\/10.1172\/JCI74527","journal-title":"J Clin Invest"},{"issue":"6","key":"10088_CR150","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1073\/pnas.1714446115","volume":"115","author":"T Souma","year":"2018","unstructured":"Souma T, Thomson BR, Heinen S et al (2018) Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP. Proc Natl Acad Sci U S A 115(6):1298\u20131303. https:\/\/doi.org\/10.1073\/pnas.1714446115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10088_CR151","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-04115-2","volume":"20","author":"YY Zheng","year":"2025","unstructured":"Zheng YY, Hua C, Lin XX (2025) PI3K\/AKT\/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials. Orphanet J Rare Dis 20:624. https:\/\/doi.org\/10.1186\/s13023-025-04115-2","journal-title":"Orphanet J Rare Dis"},{"key":"10088_CR152","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1146\/annurev.cellbio.17.1.615","volume":"17","author":"R Katso","year":"2001","unstructured":"Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD (2001) Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 17:615\u2013675. https:\/\/doi.org\/10.1146\/annurev.cellbio.17.1.615","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"10088_CR153","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cell.2018.07.003","volume":"174","author":"N Chu","year":"2018","unstructured":"Chu N, Salguero AL, Liu AZ et al (2018) Akt kinase activation mechanisms revealed using protein semisynthesis. Cell 174(4):897-907.e14. https:\/\/doi.org\/10.1016\/j.cell.2018.07.003","journal-title":"Cell"},{"issue":"7","key":"10088_CR154","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129(7):1261\u20131274. https:\/\/doi.org\/10.1016\/j.cell.2007.06.009","journal-title":"Cell"},{"issue":"43","key":"10088_CR155","doi-asserted-by":"publisher","first-page":"30896","DOI":"10.1074\/jbc.274.43.30896","volume":"274","author":"N Jones","year":"1999","unstructured":"Jones N, Master Z, Jones J et al (1999) Identification of Tek\/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274(43):30896\u201330905","journal-title":"J Biol Chem"},{"issue":"9","key":"10088_CR156","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.1189704","volume":"18","author":"C Daly","year":"2004","unstructured":"Daly C, Wong V, Burova E et al (2004) Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev 18(9):1060\u20131071. https:\/\/doi.org\/10.1101\/gad.1189704","journal-title":"Genes Dev"},{"issue":"1","key":"10088_CR157","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yexcr.2004.04.013","volume":"298","author":"LM DeBusk","year":"2004","unstructured":"DeBusk LM, Hallahan DE, Lin PC (2004) Akt is a major angiogenic mediator downstream of the Ang1\/Tie2 signaling pathway. Exp Cell Res 298(1):167\u2013177. https:\/\/doi.org\/10.1016\/j.yexcr.2004.04.013","journal-title":"Exp Cell Res"},{"issue":"1","key":"10088_CR158","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/01.RES.86.1.24","volume":"86","author":"I Kim","year":"2000","unstructured":"Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Circ Res 86(1):24\u201329. https:\/\/doi.org\/10.1161\/01.RES.86.1.24","journal-title":"Circ Res"},{"issue":"15","key":"10088_CR159","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1158\/0008-5472.CAN-05-0522","volume":"65","author":"S Kanda","year":"2005","unstructured":"Kanda S, Miyata Y, Mochizuki Y, Matsuyama T, Kanetake H (2005) Angiopoietin 1 is mitogenic for cultured endothelial cells. Cancer Res 65(15):6820\u20136827. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0522","journal-title":"Cancer Res"},{"issue":"3","key":"10088_CR160","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"issue":"5","key":"10088_CR161","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ncb1714","volume":"10","author":"S Fukuhara","year":"2008","unstructured":"Fukuhara S, Sako K, Minami T et al (2008) Differential function of Tie2 at cell\u2013cell contacts and cell\u2013substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10(5):513\u2013526. https:\/\/doi.org\/10.1038\/ncb1714","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10088_CR162","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000571","volume":"2","author":"R Echavarria","year":"2013","unstructured":"Echavarria R, Hussain SNA (2013) Regulation of angiopoietin-1\/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5. J Am Heart Assoc Cardiovasc Cerebrovasc Dis 2(6):e000571. https:\/\/doi.org\/10.1161\/JAHA.113.000571","journal-title":"J Am Heart Assoc Cardiovasc Cerebrovasc Dis"},{"issue":"9","key":"10088_CR163","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1096\/FJ.01-0805FJE","volume":"16","author":"I Kim","year":"2002","unstructured":"Kim I, Ryu YS, Kwak HJ et al (2002) EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras\/mitogen-activated protein kinase pathway in venous endothelial cells. FASEB J 16(9):1126\u20131128. https:\/\/doi.org\/10.1096\/FJ.01-0805FJE","journal-title":"FASEB J"},{"issue":"6","key":"10088_CR164","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0167","volume":"146","author":"Y Dori","year":"2020","unstructured":"Dori Y, Smith C, Pinto E et al (2020) Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation. Pediatrics 146(6):e20200167. https:\/\/doi.org\/10.1542\/peds.2020-0167","journal-title":"Pediatrics"},{"issue":"5","key":"10088_CR165","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jaad.2025.07.033","volume":"93","author":"Y Sun","year":"2025","unstructured":"Sun Y, Gu H, Zhang B et al (2025) Trametinib treatment for early-stage extracranial arteriovenous malformations: a multicenter, prospective, single-arm pilot study. J Am Acad Dermatol 93(5):1261\u20131267. https:\/\/doi.org\/10.1016\/j.jaad.2025.07.033","journal-title":"J Am Acad Dermatol"},{"issue":"30","key":"10088_CR166","doi-asserted-by":"publisher","first-page":"12432","DOI":"10.1073\/PNAS.1304188110\/-\/DCSUPPLEMENTAL","volume":"110","author":"EM Chislock","year":"2013","unstructured":"Chislock EM, Ring C, Pendergast AM (2013) Abl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survival. Proc Natl Acad Sci U S A 110(30):12432\u201312437. https:\/\/doi.org\/10.1073\/PNAS.1304188110\/-\/DCSUPPLEMENTAL","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10088_CR167","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1084\/jem.20132330","volume":"211","author":"C Raimondi","year":"2014","unstructured":"Raimondi C, Fantin A, Lampropoulou A, Denti L, Chikh A, Ruhrberg C (2014) Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1\u2013dependent ABL1 activation in endothelial cells. J Exp Med 211(6):1167\u20131183. https:\/\/doi.org\/10.1084\/jem.20132330","journal-title":"J Exp Med"},{"issue":"1","key":"10088_CR168","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010851","volume":"20","author":"JA Schumacher","year":"2024","unstructured":"Schumacher JA, Wright ZA, Rufin Florat D et al (2024) SH2 domain protein E and ABL signaling regulate blood vessel size. PLoS Genet 20(1):e1010851. https:\/\/doi.org\/10.1371\/journal.pgen.1010851","journal-title":"PLoS Genet"},{"issue":"848","key":"10088_CR169","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aeb7597","volume":"18","author":"W Tang","year":"2026","unstructured":"Tang W, Li Y, Boscolo E, Kohane DS, Cullion K (2026) Polymeric rapamycin nanoparticles encapsulating ponatinib cause regression of venous malformations in mice. Sci Transl Med 18(848):eaeb7597. https:\/\/doi.org\/10.1126\/scitranslmed.aeb7597","journal-title":"Sci Transl Med"},{"issue":"16","key":"10088_CR170","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1101\/gad.8.16.1897","volume":"8","author":"DJ Dumont","year":"1994","unstructured":"Dumont DJ, Gradwohl G, Fong GH et al (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8(16):1897\u20131909. https:\/\/doi.org\/10.1101\/gad.8.16.1897","journal-title":"Genes Dev"},{"issue":"6535","key":"10088_CR171","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato TN, Tozawa Y, Deutsch U et al (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376(6535):70\u201374. https:\/\/doi.org\/10.1038\/376070a0","journal-title":"Nature"},{"issue":"8","key":"10088_CR172","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1242\/dev.043380","volume":"137","author":"X Qu","year":"2010","unstructured":"Qu X, Tompkins K, Batts LE, Puri M, Baldwin HS (2010) Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Dev Camb Engl 137(8):1285\u20131295. https:\/\/doi.org\/10.1242\/dev.043380","journal-title":"Dev Camb Engl"},{"key":"10088_CR173","doi-asserted-by":"publisher","first-page":"e21032","DOI":"10.7554\/eLife.21032","volume":"5","author":"M Chu","year":"2016","unstructured":"Chu M, Li T, Shen B et al (2016) Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII. eLife 5:e21032. https:\/\/doi.org\/10.7554\/eLife.21032","journal-title":"eLife"},{"issue":"7","key":"10088_CR174","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200131","volume":"149","author":"N Li-Villarreal","year":"2022","unstructured":"Li-Villarreal N, Wong RLY, Garcia MD et al (2022) FOXO1 represses sprouty 2 and sprouty 4 expression to promote arterial specification and vascular remodeling in the mouse yolk sac. Development 149(7):dev200131. https:\/\/doi.org\/10.1242\/dev.200131","journal-title":"Development"},{"issue":"8","key":"10088_CR175","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1161\/ATVBAHA.122.318860","volume":"43","author":"X Cao","year":"2023","unstructured":"Cao X, Li T, Xu B et al (2023) Endothelial TIE1 restricts angiogenic sprouting to coordinate vein assembly in synergy with its homologue TIE2. Arterioscler Thromb Vasc Biol 43(8):e323\u2013e338. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318860","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10088_CR176","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","volume":"87","author":"C Suri","year":"1996","unstructured":"Suri C, Jones PF, Patan S et al (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87(7):1171\u20131180. https:\/\/doi.org\/10.1016\/S0092-8674(00)81813-9","journal-title":"Cell"},{"issue":"6","key":"10088_CR177","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1172\/JCI46322","volume":"121","author":"M Jeansson","year":"2011","unstructured":"Jeansson M, Gawlik A, Anderson G et al (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121(6):2278\u20132289. https:\/\/doi.org\/10.1172\/JCI46322","journal-title":"J Clin Invest"},{"issue":"3","key":"10088_CR178","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","volume":"3","author":"NW Gale","year":"2002","unstructured":"Gale NW, Thurston G, Hackett SF et al (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3(3):411\u2013423. https:\/\/doi.org\/10.1016\/S1534-5807(02)00217-4","journal-title":"Dev Cell"},{"issue":"5322","key":"10088_CR179","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277(5322):55\u201360. https:\/\/doi.org\/10.1126\/science.277.5322.55","journal-title":"Science"},{"issue":"4","key":"10088_CR180","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/01.RES.81.4.567","volume":"81","author":"AL Wong","year":"1997","unstructured":"Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81(4):567\u2013574. https:\/\/doi.org\/10.1161\/01.RES.81.4.567","journal-title":"Circ Res"},{"issue":"13","key":"10088_CR181","doi-asserted-by":"publisher","first-page":"9102","DOI":"10.1074\/jbc.275.13.9102","volume":"275","author":"A Papapetropoulos","year":"2000","unstructured":"Papapetropoulos A, Fulton D, Mahboubi K et al (2000) Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt\/survivin pathway. J Biol Chem 275(13):9102\u20139105. https:\/\/doi.org\/10.1074\/jbc.275.13.9102","journal-title":"J Biol Chem"},{"issue":"2","key":"10088_CR182","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/jcp.20592","volume":"207","author":"S Tsigkos","year":"2006","unstructured":"Tsigkos S, Zhou Z, Kotanidou A et al (2006) Regulation of Ang2 release by PTEN\/PI3-kinase\/Akt in lung microvascular endothelial cells. J Cell Physiol 207(2):506\u2013511. https:\/\/doi.org\/10.1002\/jcp.20592","journal-title":"J Cell Physiol"},{"issue":"7","key":"10088_CR183","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/01.RES.87.7.603\/FORMAT\/EPUB","volume":"87","author":"JR Gamble","year":"2000","unstructured":"Gamble JR, Drew J, Trezise L et al (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87(7):603\u2013607. https:\/\/doi.org\/10.1161\/01.RES.87.7.603\/FORMAT\/EPUB","journal-title":"Circ Res"},{"issue":"6","key":"10088_CR184","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2004.10.011","volume":"6","author":"F Winkler","year":"2004","unstructured":"Winkler F, Kozin SV, Tong RT et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6):553\u2013563. https:\/\/doi.org\/10.1016\/j.ccr.2004.10.011","journal-title":"Cancer Cell"},{"issue":"6","key":"10088_CR185","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1172\/JCI58832","volume":"122","author":"M Felcht","year":"2012","unstructured":"Felcht M, Luck R, Schering A et al (2012) Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122(6):1991\u20132005. https:\/\/doi.org\/10.1172\/JCI58832","journal-title":"J Clin Invest"},{"key":"10088_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252342","author":"MJ Schonning","year":"2021","unstructured":"Schonning MJ, Koh S, Sun RW et al (2021) Venous malformation vessels are improperly specified and hyperproliferative. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0252342","journal-title":"PLoS ONE"},{"issue":"6","key":"10088_CR187","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s12276-022-00785-1","volume":"54","author":"HW Lee","year":"2022","unstructured":"Lee HW, Shin JH, Simons M (2022) Flow goes forward and cells step backward: endothelial migration. Exp Mol Med 54(6):711\u2013719. https:\/\/doi.org\/10.1038\/s12276-022-00785-1","journal-title":"Exp Mol Med"},{"issue":"16","key":"10088_CR188","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/CIRCULATIONAHA.121.054071","volume":"144","author":"HW Lee","year":"2021","unstructured":"Lee HW, Xu Y, He L et al (2021) The role of venous endothelial cells in developmental and pathologic angiogenesis. Circulation 144(16):1308. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054071","journal-title":"Circulation"},{"issue":"3","key":"10088_CR189","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-026-10045-9","volume":"29","author":"M Ansarizadeh","year":"2026","unstructured":"Ansarizadeh M, Lazovic B, Sarmadian Z, Singh A, Hicks R, Eklund L (2026) A human endothelial and adipose stem cell-based co-culture model for venous malformations. Angiogenesis 29(3):30. https:\/\/doi.org\/10.1007\/s10456-026-10045-9","journal-title":"Angiogenesis"},{"issue":"7","key":"10088_CR190","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1242\/jcs.020693","volume":"121","author":"W Koh","year":"2008","unstructured":"Koh W, Mahan RD, Davis GE (2008) Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J Cell Sci 121(7):989\u20131001. https:\/\/doi.org\/10.1242\/jcs.020693","journal-title":"J Cell Sci"},{"issue":"7","key":"10088_CR191","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.116.309094","volume":"119","author":"DM Barry","year":"2016","unstructured":"Barry DM, Koo Y, Norden PR et al (2016) Rasip1-mediated Rho GTPase signaling regulates blood vessel tubulogenesis via nonmuscle myosin II. Circ Res 119(7):810\u2013826. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309094","journal-title":"Circ Res"},{"issue":"13","key":"10088_CR192","doi-asserted-by":"publisher","DOI":"10.1242\/dev.161182","volume":"145","author":"B Lavi\u00f1a","year":"2018","unstructured":"Lavi\u00f1a B, Castro M, Niaudet C et al (2018) Defective endothelial cell migration in the absence of Cdc42 leads to capillary-venous malformations. Development 145(13):dev161182. https:\/\/doi.org\/10.1242\/dev.161182","journal-title":"Development"},{"issue":"8","key":"10088_CR193","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.118.314300","volume":"124","author":"M Castro","year":"2019","unstructured":"Castro M, Lavi\u00f1a B, Ando K et al (2019) CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression. Circ Res 124(8):1240\u20131252. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.314300","journal-title":"Circ Res"},{"issue":"8","key":"10088_CR194","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1073\/pnas.071052598","volume":"98","author":"G Garc\u00eda-Carde\u00f1a","year":"2001","unstructured":"Garc\u00eda-Carde\u00f1a G, Comander J, Anderson KR, Blackman BR, Gimbrone MA (2001) Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 98(8):4478\u20134485. https:\/\/doi.org\/10.1073\/pnas.071052598","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10088_CR195","doi-asserted-by":"publisher","first-page":"e04645","DOI":"10.7554\/eLife.04645","volume":"4","author":"N Baeyens","year":"2015","unstructured":"Baeyens N, Nicoli S, Coon BG et al (2015) Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point. eLife 4:e04645. https:\/\/doi.org\/10.7554\/eLife.04645","journal-title":"eLife"},{"issue":"3","key":"10088_CR196","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1172\/JCI83083","volume":"126","author":"N Baeyens","year":"2016","unstructured":"Baeyens N, Bandyopadhyay C, Coon BG, Yun S, Schwartz MA (2016) Endothelial fluid shear stress sensing in vascular health and disease. J Clin Invest 126(3):821\u2013828. https:\/\/doi.org\/10.1172\/JCI83083","journal-title":"J Clin Invest"},{"issue":"1","key":"10088_CR197","doi-asserted-by":"publisher","DOI":"10.1063\/5.0234507","volume":"9","author":"WY Aw","year":"2025","unstructured":"Aw WY, Sawhney A, Rathod M et al (2025) Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations. APL Bioeng 9(1):016106. https:\/\/doi.org\/10.1063\/5.0234507","journal-title":"APL Bioeng"},{"issue":"2","key":"10088_CR198","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0006-291x(03)00592-8","volume":"304","author":"HJ Lee","year":"2003","unstructured":"Lee HJ, Koh GY (2003) Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells. Biochem Biophys Res Commun 304(2):399\u2013404. https:\/\/doi.org\/10.1016\/s0006-291x(03)00592-8","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10088_CR199","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202216128","volume":"15","author":"K Shirakura","year":"2023","unstructured":"Shirakura K, Baluk P, Nottebaum AF et al (2023) Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration. EMBO Mol Med 15(4):e16128. https:\/\/doi.org\/10.15252\/emmm.202216128","journal-title":"EMBO Mol Med"},{"key":"10088_CR200","doi-asserted-by":"publisher","DOI":"10.1038\/srep05457","volume":"4","author":"G Chen","year":"2014","unstructured":"Chen G, Ren JG, Zhang W et al (2014) Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-\u03b2. Sci Rep 4:5457. https:\/\/doi.org\/10.1038\/srep05457","journal-title":"Sci Rep"},{"issue":"2","key":"10088_CR201","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jvsv.2021.08.020","volume":"10","author":"J Zhu","year":"2022","unstructured":"Zhu J, Tang Z, Ren J et al (2022) Downregulation of microRNA-21 contributes to decreased collagen expression in venous malformations via transforming growth factor-\u03b2\/Smad3\/microRNA-21 signaling feedback loop. J Vasc Surg Venous Lymphat Disord 10(2):469-481.e2. https:\/\/doi.org\/10.1016\/j.jvsv.2021.08.020","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"3","key":"10088_CR202","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/S00441-022-03657-2\/FIGURES\/6","volume":"389","author":"GH Chen","year":"2022","unstructured":"Chen GH, Yang JG, Xia HF et al (2022) Endothelial cells induce degradation of ECM through enhanced secretion of MMP14 carried on extracellular vesicles in venous malformation. Cell Tissue Res 389(3):517\u2013530. https:\/\/doi.org\/10.1007\/S00441-022-03657-2\/FIGURES\/6","journal-title":"Cell Tissue Res"},{"issue":"4","key":"10088_CR203","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10456-016-9519-4","volume":"19","author":"R Zhang","year":"2016","unstructured":"Zhang R, Han Z, Degos V et al (2016) Persistent infiltration and pro-inflammatory differentiation of monocytes cause unresolved inflammation in brain arteriovenous malformation. Angiogenesis 19(4):451\u2013461. https:\/\/doi.org\/10.1007\/s10456-016-9519-4","journal-title":"Angiogenesis"},{"issue":"7654","key":"10088_CR204","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature22075","volume":"545","author":"AT Tang","year":"2017","unstructured":"Tang AT, Choi JP, Kotzin JJ et al (2017) Endothelial TLR4 and the microbiome drive cerebral cavernous malformations. Nature 545(7654):305\u2013310. https:\/\/doi.org\/10.1038\/nature22075","journal-title":"Nature"},{"issue":"11","key":"10088_CR205","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.122.321129","volume":"131","author":"CC Lai","year":"2022","unstructured":"Lai CC, Nelsen B, Frias-Anaya E et al (2022) Neuroinflammation plays a critical role in cerebral cavernous malformation disease. Circ Res 131(11):909\u2013925. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321129","journal-title":"Circ Res"},{"key":"10088_CR206","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1622961","volume":"13","author":"L Liu","year":"2025","unstructured":"Liu L, Wang L, Luo J et al (2025) Endothelial GNAQ p.R183Q mutation confers hemoporfin-mediated photodynamic therapy resistance and drives pathological angiogenesis via the angiopoietin-2\/TIE2\/PI3K\/AKT pathway. Front Cell Dev Biol 13:1622961. https:\/\/doi.org\/10.3389\/fcell.2025.1622961","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10088_CR207","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20251374","volume":"223","author":"L Li","year":"2026","unstructured":"Li L, Castro M, Hongo H et al (2026) TIE2 links MEKK3\u2013KLF2\/4 and PI3K signaling in cerebral cavernous malformation. J Exp Med 223(5):e20251374. https:\/\/doi.org\/10.1084\/jem.20251374","journal-title":"J Exp Med"},{"issue":"18","key":"10088_CR208","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168352","volume":"133","author":"K Banerjee","year":"2023","unstructured":"Banerjee K, Lin Y, Gahn J et al (2023) SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations. J Clin Invest 133(18):e168352. https:\/\/doi.org\/10.1172\/JCI168352","journal-title":"J Clin Invest"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10456-026-10088-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-026-10088-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:50:58Z","timestamp":1787244658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10456-026-10088-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":208,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["10088"],"URL":"https:\/\/doi.org\/10.1007\/s10456-026-10088-y","relation":{},"ISSN":["1573-7209"],"issn-type":[{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"62"}}